This inventor holds 2 USPTO granted patents. Top assignee: Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2008
Title: The Innovative Contributions of Katsunori Maruta in Pharmaceutical Patents
Introduction: Katsunori Maruta, an accomplished inventor based in Osaka, Japan, has made significant strides in the pharmaceutical field with his innovative contributions. With a total of two patents to his name, he has focused on developing compounds with notable therapeutic effects.
Latest Patents: Katsunori Maruta's latest patents showcase his expertise in medicinal chemistry. One of his notable inventions is a heteroaryl derivative, characterized by a specific structural formula that includes various substitutions and functional groups. This compound can be utilized as a prodrug or a pharmaceutically acceptable salt, providing potential advancements in pharmacology. Additionally, he has developed a novel pyrrole derivative, which demonstrates antidiabetic activity. This derivative's unique structure allows for various substitutions, enhancing its therapeutic potential in diabetes management.
Career Highlights: Throughout his career, Katsunori Maruta has been affiliated with Dainippon Sumitomo Pharma Co., Ltd., a reputable pharmaceutical company known for its commitment to innovation and excellence in drug development. His work has contributed to the advancement of treatments aimed at improving patients’ lives.
Collaborations: Maruta has had the pleasure of working alongside esteemed colleagues such as Kantaro Ushiroda and Ryu Nagata. Their collaborative efforts have likely fostered an environment rich in creativity and academic exploration, further driving the development of groundbreaking pharmaceutical innovations.
Conclusion: Katsunori Maruta's contributions to the pharmaceutical industry through his innovative inventions and collaborations exemplify his dedication to enhancing therapeutic options. His patents not only reflect his technical expertise but also underscore the potential impact of his work on patients' health and well-being. As he continues to innovate, the pharmaceutical community eagerly anticipates his future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile